<?xml version='1.0' encoding='utf-8'?>
<CERIF xmlns='urn:xmlns:org:eurocris:cerif-1.5-1' xsi:schemaLocation='urn:xmlns:org:eurocris:cerif-1.5-1 http://www.eurocris.org/Uploads/Web%20pages/CERIF-1.5/CERIF_1.5_1.xsd' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' release='1.5' date='2012-10-07' sourceDatabase='Output Profile'>
<cfResPubl>
<cfResPublId>ibn-ResPubl-28551</cfResPublId>
<cfResPublDate>2013-05-01</cfResPublDate>
<cfVol>14</cfVol>
<cfIssue>3</cfIssue>
<cfStartPage>741</cfStartPage>
<cfISSN>1857-1719</cfISSN>
<cfURI>https://ibn.idsi.md/ro/vizualizare_articol/28551</cfURI>
<cfTitle cfLangCode='RO' cfTrans='o'>Particularităţi clinice si paraclinice ale borreliozei lyme la pacienţii internaţi in SCBI ,,T. Ciorbă” pe parcursul anilor 2009-2012  </cfTitle>
<cfAbstr cfLangCode='RO' cfTrans='o'>Am elucidatat particularitățile clinice epidemiologice si paraclinice la pacienții internați in SCBI ,, T.Ciorbă’’ ( 39 persoane) pe durata anilor 2009-2012. Boala Lyme s-a constatat cel mai frecvent în luna mai (33.3%) și iulie (20.5%). Maladia a evoluat în majoritatea cazurilor cu eritem migrator (EM) la 66%, artralgii- la 64%, senzații de arsuri locale-la 58%, cefalee-la 46% și febră la 30% pacienți. EM și artralgiile s-au constat la femei cu o frecvența mai mare decat la barbați 18 vs 8 și 15 vs 10 corespunzător. La alte simptome frecvența a fost similară. Perioada de incubație varia între 9.36 și 17.96 zile.</cfAbstr>
<cfAbstr cfLangCode='EN' cfTrans='o'>There have been examined and treated 39 patients suffering with acute Lyme Disease (LD) during 2009-2012 in the Clinic of Infectious Disease. The incidence of disease was higher during May and July months 33.3% and 20.5% accordingly The most commonly noticed symptom was erythema migratory (EM) in 66% cases, followed by arthralgia and myalgia - in 64, local burning sensations –in 58, head ache- in 46 and fever –in 30% cases. EM syndrome was more frequently noticed in women – in 18 cases vs 8- in men. Also joint pain was a more frequent symptom presented by women 15 vs 10 cases in men. Incubation period was 14 and 13.13 days.</cfAbstr>
<cfResPubl_Class>
<cfClassId>eda2d9e9-34c5-11e1-b86c-0800200c9a66</cfClassId>
<cfClassSchemeId>759af938-34ae-11e1-b86c-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfResPubl_Class>
<cfClassId>e601872f-4b7e-4d88-929f-7df027b226c9</cfClassId>
<cfClassSchemeId>40e90e2f-446d-460a-98e5-5dce57550c48</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfResPubl_Class>
<cfPers_ResPubl>
<cfPersId>ibn-person-1192</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
<cfPers_ResPubl>
<cfPersId>ibn-person-251</cfPersId>
<cfClassId>49815870-1cfe-11e1-8bc2-0800200c9a66</cfClassId>
<cfClassSchemeId>b7135ad0-1d00-11e1-8bc2-0800200c9a66</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
</cfPers_ResPubl>
</cfResPubl>
<cfPers>
<cfPersId>ibn-Pers-1192</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-1192-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
<cfFamilyNames>Chiriac</cfFamilyNames>
<cfFirstNames>Ion</cfFirstNames>
</cfPersName_Pers>
</cfPers>
<cfPers>
<cfPersId>ibn-Pers-251</cfPersId>
<cfPersName_Pers>
<cfPersNameId>ibn-PersName-251-2</cfPersNameId>
<cfClassId>55f90543-d631-42eb-8d47-d8d9266cbb26</cfClassId>
<cfClassSchemeId>7375609d-cfa6-45ce-a803-75de69abe21f</cfClassSchemeId>
<cfStartDate>2013-05-01T24:00:00</cfStartDate>
<cfFamilyNames>Holban</cfFamilyNames>
<cfFirstNames>Tiberiu</cfFirstNames>
</cfPersName_Pers>
</cfPers>
</CERIF>